Hospital Based Cause Of Death Statistics

A National Hospital Based Mortality Notification system (HMS) was established at the beginning of 2017 in collaboration with the World Health Organization and in cooperation with the Syndicate of hospitals as an expansion of the maternal and neonatal death reporting system established in 2011. The system consists of anonymous online reporting of deaths based on an excerpt of the official death certificate form. Focal points were assigned and trained in more than 150 public and private hospitals operating in Lebanon. After reporting the information, quality checks are initiated through constant communication between the statistics department and the hospitals’ focal points. After that, the underlying cause of death is selected from the reported causes of the death.

Hospital Mortality Statistics 2025

Hospital Deaths due to COVID-19 by Week, 2020-2025 (till August 2025)

Hospital Deaths due to COVID-19 by Month, 2020-2025 (till August 2025)

Hospital Mortality Statistics 2024

Number of reported hospital deaths and proportional mortality due to malignant neoplasms, 2017-2024

Top Cancer Killers In Men and Women,2024

Hospital Mortality Statistics 2022

Top Cancer Killers in Men and Women, 2022

Hospital Mortality Statistics 2021

Number of reported Lebanese hospital deaths by month and age group

Number of reported hospital deaths by month and age group in Lebanon

Number of reported COVID-19 hospital deaths by month and age group

Weekly Total Hospital Deaths and COVID19 Related Deaths

Hospital Mortality Statistics 2020 and 2021

Weekly Total Hospital Deaths and COVID19 Related Deaths 2020&2021

Hospital Mortality Statistics 2020

Number of reported Lebanese hospital deaths by month and age group

Number of reported hospital deaths by month and age group in Lebanon

Number of reported COVID-19 hospital deaths by month and age group in Lebanon

Weekly Total Hospital Deaths and COVID19 Related Deaths

Hospital Mortality Statistics 2019

Number of reported Lebanese hospital deaths by month and age group, 2019

Number of reported hospital deaths by month and age group in Lebanon, 2019 (Updated)

Hospital Mortality Statistics 2018

Number of reported Lebanese hospital deaths by month and age group, 2018

Number of reported hospital deaths by month and age group in Lebanon, 2018 

Hospital Mortality Statistics 2017

Number of reported Lebanese hospital deaths by month and age group, 2017

Number of reported hospital deaths by month and age group in Lebanon, 2017

Reported hospital deaths by top ICD10 chapters, 2017

Top 10 cancers by ICD10 3-character code, 2017

Plot of the number of the reported deaths by size and type of hospital, 2017

Five leading cancer deaths by gender, 2017

Top 10 leading causes of reported hospital deaths by ICD10 4-character code and gender, 2017

Proportion of reported hospital deaths by age group and gender in Lebanon, 2017

ATC	Name	B/G	Ingredients	Form	Price
J07BH01	ROTARIX ORAL	B	Rota virus human RIX4414, live attenuated - ≥106 CCID50	Suspension	5,167,074 L.L
N02AJ13	TRAMADOL/PARACETAMOL ARROW LAB	G	Tramadol - 37.5mg, Paracetamol - 325mg	Tablet, coated	205,608 L.L
R02A	TRACHISAN	G	Lidocaine HCl - 1mg, Tyrothricin - 0.5mg, Chlorhexidine gluconate - 1mg	Lozenge	228,453 L.L
L01BA04	PEMETREXED NEAPOLIS	G	Pemetrexed (disodium) - 500mg	Injectable powder	L.L
B03AD03	GYNO-TARDYFERON	B	Folic acid - 0.35mg, Ferrous (sulfate) - 80mg	Tablet, sugar coated, slow release	819,744 L.L
J07BH01	ROTASIIL, ROTAVIRUS VACCINE, LIVE ATTENUATED (ORAL FREEZE-DRIED)	BioTech	Rotavirus bovine-human , live attenuated -	Suspension	2,822,069 L.L
N02AJ14	LENIZAK	B	Tramadol HCl - 75mg, Dexketoprofen - 25mg	Tablet, film coated	494,534 L.L
R02A	CHLORASEPTIC TOTAL SORE THROAT + COUGH LOZENGES WILD CHERRY	G	Benzocaine - 6mg, Dextromethorphan - 5mg, Menthol - 10mg	Lozenge	537,537 L.L
B03AD03	FOLIFER	G	Folic acid - 1mg, Iron bivalent (as dried ferrous sulfate) - 90mg	Tablet, film coated	1,408,347 L.L
J07BH01	ROTASIIL, ROTAVIRUS VACCINE, LIVE ATTENUATED (ORAL LIQUID)	BioTech	Rotavirus bovine-human , live attenuated -	Liquid	2,822,069 L.L
R02AA05	GOLASEPTINE-LIDOCAINE	G	Chlorhexidine HCl - 5mg, Lidocaine HCl - 1mg	Tablet, chewable	736,426 L.L
D10AF51	DUAC ONCE DAILY	B	Clindamycin (phosphate) - 1%, Benzoyl peroxide - 5%	Gel	1,658,302 L.L
G04BX14	PRIXETIN 60	G	Dapoxetine (hydrochloride) - 60mg	Tablet, film coated	1,479,123 L.L
J07BK01	VARIVAX	B	Varicella virus, live attenuated - 1350PFU	Injectable powder for suspension+diluent	4,102,751 L.L
J07BK01	VARICELLA VACCINE LIVE	BioTech	Varicella-herpes zoster virus (Oka strain), grown in human diploid cells (SV-cell line), live attenuated -	Injectable suspension	3,104,276 L.L
J07BL01	YELLOW FEVER VACCINE, LIVE, FREEZE DRIED	BioTech	Yellow Fever virus, 17D strain - no less than 1600PFU/0.5ml	Injectable lyophilisate for solution	3,527,587 L.L
B03AE02	ELEVIT PRONATAL	G	Vitamin A, palmitate - 1080mcg, Vitamin B1 - 1.6mg, Vitamin B2 - 1.8mg, Vitamin B6 - 2.6mg, Vitamin B12 - 4mcg, Vitamin C - 100mg, Vitamin D3 - 12.5mcg, Vitamin E - 15mg, Biotin - 0.2mg, Calcium Pantothenate - 10mg, Folic acid - 0.8mg, Nicotinamide - 19mg, Calcium - 125mg, Magnesium - 100mg, Phosphorous - 125mg, Iron - 60mg, Copper - 1mg, Manganese - 1mg, Zinc - 7.5mg	Tablet, film coated	893,655 L.L
J07BM03	GARDASIL 9 HUMAN PAPILLOMAVIRUS 9- VALENT VACCINE RECOMBINANT	B	Papillomavirus (human type 6) - 30mcg/0.5ml, Papillomavirus (human type 11) - 40mcg/0.5ml, Papillomavirus (human type 16) - 60mcg/0.5ml, Papillomavirus (human type 18) - 40mcg/0.5ml, Papillomavirus (human type 31) - 20mcg/0.5ml, Papillomavirus (human type 33) - 20mcg/0.5ml, Papillomavirus (human type 45) - 20mcg/0.5ml, Papillomavirus (human type 52) - 20mcg/0.5ml, Papillomavirus (human type 58) - 20mcg/0.5ml	Injectable suspension	14,139,396 L.L
B03AE10	TOT'HEMA	B	Copper (gluconate) - 0.70mg/10ml, Manganese (gluconate) - 1.33mg/10ml, Iron (gluconate) - 50mg/10ml	Solution	604,729 L.L
J07BX05	ABRYSVO	B	RSV subgroup A stabilized perfusion F antigen 60mcg - 60mcg, RSV subgroup B stabilized perfusion F antigen 60mcg - 60mcg, Glycoprotein F stabilized in the perfusion conformation -	Injectable powder + solvent	22,650,721 L.L
J07CA	LANTIGEN B	B	Streptococcus pneumoniae type 3 (antigenic extracts) - 63.2A.U./ml, Streptococcus pyogenes group A (antigenic extracts) - 126.2A.U./ml, Branhamella catarrhalis (antigenic extracts) - 39.9A.U./ml, Staphylococcus aureus (antigenic extracts) - 79.6A.U./ml, Haemophilus influenzae type b (antigenic extracts) - 50.2A.U./ml, Klebsiella pneumoniae (antigenic extracts) - 39.8A.U./ml	Drops suspension	916,501 L.L
J07CA02	TETRAXIM (Vaccin Diphterique, tetanique, coquelucheux acellulaire et Poliomyelitique inactivé adsorbé)	B	Diphteria toxoid purified - ≥30IU, Tetanus toxoid purified - ≥40IU, Poliomyelitis virus type 1 inactivated - 40D.U., Poliomyelitis virus type 2 inactivated - 8D.U., Poliomyelitis virus type 3 inactivated - 32D.U., Bordetella Pertussis Antigens: toxoid - 25mcg, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg	Injectable suspension	1,628,737 L.L
J07CA06	INFANRIX IPV + HIB	B	Poliomyelitis virus type 3 inactivated(Prefilled syringe) - 32D.U., Poliomyelitis virus type 2 inactivated(Prefilled syringe) - 8D.U., Poliomyelitis virus type 1 inactivated(Prefilled syringe) - 40D.U., Bordetella pertussis antigen(Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg, Tetanus toxoid (Prefilled syringe) - ≥40IU, Diphtheria toxoid (Prefilled syringe) - ≥30IU, H. Influenza type b polysaccharide(Vial) - 10mcg	Injectable dry powder+suspension	3,014,239 L.L
J07CA06	PENTAXIM	B	Poliomyelitis virus type 3 inactivated(Prefilled syringe) - 32D.U., Poliomyelitis virus type 2 inactivated(Prefilled syringe) - 8D.U., Poliomyelitis virus type 1 inactivated(Prefilled syringe) - 40D.U., Bordetella pertussis antigen (Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg, Tetanus toxoid (Prefilled syringe) - ≥40IU, Diphtheria toxoid (Prefilled syringe) - ≥30IU, H. Influenza type b polysaccharide(Vial) - 10mcg	Injectable dry powder+suspension	2,558,676 L.L
B03BA51	DEPOVEX	B	Aluminium monostearate - 20mg/ml, Cyanocobalamine - 1mg/ml	Injectable oily suspension	423,310 L.L
J07CA09	INFANRIX HEXA	B	Diphteria toxoid purified (Prefilled syringe) - ≥30IU/0.5ml, Tetanus toxoid purified (prefilled syringe) - ≥40IU/0.5ml, Bordetella pertussis antigen (Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg/0.5ml, Poliomyelitis virus type 1 antigen (prefilled syringe) - 40D.U./0.5ml, Poliomyelitis virus type 2 antigen(prefilled syringe) - 8D.U./0.5ml, Poliomyelitis virus type 3 antigen (prefilled syringe) - 32D.U./0.5ml, HBs Antigen (prefilled syringe) - 10mcg/0.5ml, H. Influenza type b polysaccharide (Vial) - 10mcg/0.5ml	Injectable suspension	4,230,416 L.L
N02BA51	ASPIRINE C EFFERVESCENT	B	Acetylsalicylic acid - 400mg, Vitamin C - 240mg	Tablet, effervescent	162,605 L.L
R03AK06	SERETIDE DISKUS 100	B	Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 100mcg/inhalation	Inhalation powder	2,276,469 L.L
J07CA09	HEXAXIM	BioTech	Diphteria Toxoid - ≥20IU/0.5ml, Tetanus toxoid - ≥40IU/0.5ml, Bordetella Pertussis Antigens: toxoid - 25mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, Hepatitis B, surface antigen - 10mcg/0.5ml, H. Influenza type b polysaccharide1 ,2 - 12mcg/0.5ml, 1 conjugated to tetanus protein - 22-36mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - 0.6mg	Injectable suspension	4,462,901 L.L
N02BA51	ASPRIVIT	G	Acetylsalicylic acid - 500mg, Caffeine - 50mg, Vitamin B1 - 2mg	Tablet	186,794 L.L

Rota virus human RIX4414, live attenuated - ≥106 CCID50

Suspension

5,167,074 L.L